Pfizer and J&J end development of Alzheimer's drug
Pfizer Inc. and Johnson & Johnson say they are ending development of a once-promising drug designed to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials.
Aug 6, 2012
0
0